MX2022010954A - Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. - Google Patents

Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Info

Publication number
MX2022010954A
MX2022010954A MX2022010954A MX2022010954A MX2022010954A MX 2022010954 A MX2022010954 A MX 2022010954A MX 2022010954 A MX2022010954 A MX 2022010954A MX 2022010954 A MX2022010954 A MX 2022010954A MX 2022010954 A MX2022010954 A MX 2022010954A
Authority
MX
Mexico
Prior art keywords
methods
misfolded proteins
proteins
disorders
use therof
Prior art date
Application number
MX2022010954A
Other languages
English (en)
Inventor
Wendy L Davis
Daniel Levenson
Original Assignee
Gestvision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gestvision Inc filed Critical Gestvision Inc
Publication of MX2022010954A publication Critical patent/MX2022010954A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a dispositivos de diagnóstico, así como a métodos de uso de estos dispositivos para detectar las proteínas de interés asociadas con enfermedades o trastornos en mamíferos; en particular, las proteínas de interés pueden ser proteínas mal plegadas asociadas con ciertos trastornos de proteínas mal plegadas en mamíferos que incluyen esos mamíferos que se sospecha que tienen o que están en riesgo de tener esos trastornos.
MX2022010954A 2015-07-15 2018-01-12 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo. MX2022010954A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562192962P 2015-07-15 2015-07-15

Publications (1)

Publication Number Publication Date
MX2022010954A true MX2022010954A (es) 2022-10-07

Family

ID=57758210

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018000528A MX395376B (es) 2015-07-15 2016-07-15 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
MX2022010954A MX2022010954A (es) 2015-07-15 2018-01-12 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018000528A MX395376B (es) 2015-07-15 2016-07-15 Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.

Country Status (14)

Country Link
US (5) US10564153B2 (es)
EP (2) EP3322985B1 (es)
JP (3) JP6885608B2 (es)
CN (2) CN108291905B (es)
AR (1) AR105379A1 (es)
AU (2) AU2016293547C1 (es)
CA (1) CA2989444A1 (es)
DK (1) DK3322985T3 (es)
ES (1) ES2903034T3 (es)
MX (2) MX395376B (es)
PL (1) PL3322985T3 (es)
PT (1) PT3322985T (es)
TW (3) TWI856560B (es)
WO (1) WO2017011727A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112016004413T5 (de) * 2015-09-29 2018-08-02 Hamamatsu Photonics K.K. Verfahren zum reinigen von reinem thioflavin t, verfahren zum herstellen von reinem thioflavin t, zusammensetzung, die thioflavin t enthält, und amyloid-nachweisverfahren
US20210156853A1 (en) * 2017-12-28 2021-05-27 Shuwen Biotech Co., Ltd. Devices, kits and methods for detecting misfolded proteins
TWI698641B (zh) * 2017-12-28 2020-07-11 大陸商浙江數問生物技術有限公司 一種檢測錯誤折疊蛋白質的裝置、試劑盒和方法
US12436155B2 (en) 2020-04-16 2025-10-07 Kalia Health, Inc. Preeclampsia screening device and methods measuring activin and/or inhibin A
US20230131712A1 (en) * 2020-04-30 2023-04-27 Daxor Corp. Blood volume measurement with fluorescent dye
WO2022105923A1 (zh) 2020-11-21 2022-05-27 浙江数问生物技术有限公司 用于检测生物样本中的错误折叠蛋白质的装置和方法
EP4308928A4 (en) * 2021-03-19 2025-02-19 Kenota Inc. Assay membrane test region localization

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2684488A (en) * 1988-06-27 1990-01-04 Carter-Wallace, Inc. Test device and method for colored particle immunoassay
US5252496A (en) * 1989-12-18 1993-10-12 Princeton Biomeditech Corporation Carbon black immunochemical label
US5451504A (en) * 1991-07-29 1995-09-19 Serex, Inc. Method and device for detecting the presence of analyte in a sample
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
US6800488B2 (en) * 2000-12-13 2004-10-05 Lifescan, Inc. Methods of manufacturing reagent test strips
GB2391068A (en) 2002-07-18 2004-01-28 Sensor Tech Ltd A lateral flow through device comprising an electrochemical sesor
JP2006526786A (ja) * 2003-06-03 2006-11-24 バイエル・ヘルスケア・エルエルシー 反射率値を使用する試薬試験ストリップの自動識別
US20070054322A1 (en) * 2003-07-31 2007-03-08 Hadasit Medical Research Services & Development Lt Methods and kits for the detection of prion diseases
AU2004298660B2 (en) * 2003-12-12 2010-04-22 Abbott Rapid Diagnostics International Unlimited Company Assay
US7763454B2 (en) 2004-07-09 2010-07-27 Church & Dwight Co., Inc. Electronic analyte assaying device
DK1804836T3 (da) * 2004-09-24 2011-01-24 Beth Israel Hospital Fremgangsmåder til diagnosticering og behandling af graviditetskomplikationer
EP1946121A2 (en) 2005-10-27 2008-07-23 Yale University, Inc. Urinary proteomic biomarker patterns in preeclampsia
TW200801190A (en) * 2005-11-21 2008-01-01 Trustees Of The University Of Alabama For And On Behalf Of The University Of Board Of Regulators of protein misfolding and aggregation and methods of using the same
CA2654931C (en) * 2006-06-20 2015-05-19 Amic Ab Assay device and method with improved control functions
CA2690904C (en) 2007-06-27 2015-11-03 Inbios International, Inc. Lateral flow assay system and methods for its use
WO2010062377A2 (en) * 2008-10-31 2010-06-03 Yale University Methods and compositions for the detection and treatment of preeclampsia
CN102356161A (zh) * 2009-03-19 2012-02-15 株式会社钟化 核酸的检测方法以及试剂盒、装置
TWM384314U (en) * 2010-01-29 2010-07-11 Nat Univ Chin Yi Technology Protein folding calculation device
JP2012068064A (ja) * 2010-09-22 2012-04-05 Pilot Ink Co Ltd 液体試料検査具及び液体検査具の採液部構造
DE102011003944A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
EP2602620A1 (en) 2011-12-07 2013-06-12 Nxp B.V. An electronic lateral flow test arrangement and method
IN2014CN04326A (es) * 2011-12-15 2015-09-04 Pronota Nv
CN104704364B (zh) * 2012-06-15 2018-12-04 韦恩州立大学 用于先兆子痫和/或hellp综合征的预测或早期检测的生物标记物测试
CN105979962A (zh) * 2012-12-07 2016-09-28 比奥根国际神经科学公司 使用抗Aβ抗体减少脑淀粉样蛋白斑块的方法
MX2015010174A (es) 2013-02-08 2016-03-31 Univ Iowa Res Found Herramientas de diagnostico para predecir la presentacion de preeclampsia.
JP6182027B2 (ja) * 2013-09-10 2017-08-16 デンカ生研株式会社 Ｂ型インフルエンザウイルスの測定方法
CA3157573C (en) * 2014-04-10 2025-11-18 Yale University METHODS AND COMPOSITIONS FOR DETECTING MISFOLDED PROTEINS
TWM494304U (zh) * 2014-10-31 2015-01-21 Anatech Co Ltd 非酵素型糖化血色素檢測裝置

Also Published As

Publication number Publication date
AU2016293547A1 (en) 2018-01-18
DK3322985T3 (da) 2022-01-17
WO2017011727A1 (en) 2017-01-19
AR105379A1 (es) 2017-09-27
PL3322985T3 (pl) 2022-02-21
EP3322985B1 (en) 2021-10-13
US20170016891A1 (en) 2017-01-19
AU2016293547C1 (en) 2023-06-29
EP3322985A4 (en) 2019-01-09
US20200141932A1 (en) 2020-05-07
EP3322985A1 (en) 2018-05-23
MX2018000528A (es) 2018-08-21
MX395376B (es) 2025-03-25
TW202331255A (zh) 2023-08-01
CN108291905A (zh) 2018-07-17
PT3322985T (pt) 2022-01-13
TWI744239B (zh) 2021-11-01
TWI800009B (zh) 2023-04-21
US11073516B2 (en) 2021-07-27
BR112017028627A2 (pt) 2018-09-04
CN111965343B (zh) 2023-05-09
JP2023027284A (ja) 2023-03-01
HK1247282A1 (zh) 2018-09-21
US20230251251A1 (en) 2023-08-10
AU2023201820A1 (en) 2023-04-27
JP2021073434A (ja) 2021-05-13
TW202208853A (zh) 2022-03-01
JP6885608B2 (ja) 2021-06-16
JP2018527587A (ja) 2018-09-20
CA2989444A1 (en) 2017-01-19
TW201716778A (zh) 2017-05-16
ES2903034T3 (es) 2022-03-30
JP7648188B2 (ja) 2025-03-18
CN111965343A (zh) 2020-11-20
US20210318299A1 (en) 2021-10-14
TWI856560B (zh) 2024-09-21
CN108291905B (zh) 2020-09-11
AU2016293547B2 (en) 2023-03-09
US20250306019A1 (en) 2025-10-02
EP4036574A1 (en) 2022-08-03
US10564153B2 (en) 2020-02-18

Similar Documents

Publication Publication Date Title
MX2022010954A (es) Dispositivo para la deteccion de proteinas mal plegadas y metodos de uso del mismo.
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
IL281579B (en) Compositions and methods for detecting a biological contaminant
MX383494B (es) Ácidos nucleicos libres de células para el análisis del microbioma humano y componentes del mismo.
PL3482209T3 (pl) Oznaczenie do wykrywania alfa-synukleiny i sposób diagnozowania alfa-synukleinopatii
BR112016004305A2 (pt) métodos diagnósticos e composições para tratamento de glioblastoma
MX383381B (es) Métodos y composiciones para detectar proteínas mal plegadas.
MX2016005631A (es) Anticuerpos anti-alfa-sinucleina y metodos de uso.
BR112014031365A2 (pt) métodos de detectar doenças ou condições
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MX2017011486A (es) Métodos de detección y cuantificación de il-13 y sus usos en el diagnóstico y tratamiento de enfermedades asociadas a th2.
MX374652B (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifármaco.
PT3200582T (pt) Composições, kits e métodos para induzir citorresistência adquirida com utilização de indutores de proteínas de stress
BR112016024494A2 (pt) análogos de peptídeo com sonda(s) de aminoácidos ramificados
AR107786A1 (es) Métodos y composiciones para la detección y el diagnóstico de enfermedad renal y enfermedad periodontal
BR112017009792A2 (pt) anticorpos anti-pdgf-b e métodos de uso
IT201600073964A1 (it) Nanointerruttore basato su nucleotidi e metodi per la rilevazione di anticorpi e altri analiti
SA518391028B1 (ar) Cd37 أجسام مضادة واختبارات للكشف عن
EA201992883A1 (ru) АНТИТЕЛА К TrkB
MX385216B (es) Prueba de diagnostico basada en fragmento de rgma.
BR112018010764A2 (pt) método para detectar atividade bacteriana em uma amostra biológica e unidade de detecção correspondente
MX2017006075A (es) Biomarcadores para la progresion de enfermedades en melanoma.
DK3160645T3 (da) Indretning og fremgangsmåde til bestemmelse af en analyt i blod
MX384636B (es) Método para detectar anticuerpos neutralizantes contra la insulina humana recombinante en suero humano.
BR112016020043A2 (pt) composições e métodos para a identificação de malignidades de linfócitos b responsivas à terapia de depleção de linfócitos b